Study reveals potential therapy targets for triple-negative breast cancer

In cancer, cell signaling pathways are the critical chain of events that can either quash or quicken disease progression. A new study has revealed new information about how molecules called long non-coding RNAs (lncRNA) interact with HIF-1, a signaling pathway that is overexpressed in many cancers. HIF-1 has been shown to regulate breast cancer progression.